Seven Eight Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-41,779
Closed -$753K 582
2024
Q3
$753K Sell
41,779
-43,375
-51% -$782K 0.07% 474
2024
Q2
$1.38M Buy
+85,154
New +$1.38M 0.14% 245
2023
Q3
Sell
-12,260
Closed -$92.3K 742
2023
Q2
$92.3K Sell
12,260
-57,849
-83% -$436K 0.02% 470
2023
Q1
$620K Sell
70,109
-1,188
-2% -$10.5K 0.13% 209
2022
Q4
$650K Buy
+71,297
New +$650K 0.17% 181
2022
Q3
Sell
-168,607
Closed -$1.27M 627
2022
Q2
$1.27M Sell
168,607
-238,748
-59% -$1.8M 0.51% 42
2022
Q1
$3.83M Buy
407,355
+238,158
+141% +$2.24M 0.51% 49
2021
Q4
$1.36M Sell
169,197
-164,524
-49% -$1.32M 0.24% 130
2021
Q3
$3.25M Buy
333,721
+197,295
+145% +$1.92M 0.31% 96
2021
Q2
$1.35M Buy
+136,426
New +$1.35M 0.19% 184
2020
Q2
Sell
-21,200
Closed -$190K 548
2020
Q1
$190K Buy
+21,200
New +$190K 0.05% 402
2019
Q4
Sell
-35,845
Closed -$247K 769
2019
Q3
$247K Sell
35,845
-1,170,300
-97% -$8.06M 0.01% 558
2019
Q2
$11.1M Buy
+1,206,145
New +$11.1M 0.59% 38
2019
Q1
Sell
-221,679
Closed -$3.42M 726
2018
Q4
$3.42M Buy
+221,679
New +$3.42M 0.19% 151
2017
Q2
Sell
-17,100
Closed -$549K 673
2017
Q1
$549K Buy
17,100
+15,500
+969% +$498K 0.11% 255
2016
Q4
$58K Sell
1,600
-75,500
-98% -$2.74M 0.01% 497
2016
Q3
$3.55M Buy
+77,100
New +$3.55M 1.04% 8
2016
Q2
Sell
-31,800
Closed -$1.7M 667
2016
Q1
$1.7M Buy
31,800
+28,200
+783% +$1.51M 0.72% 25
2015
Q4
$236K Buy
+3,600
New +$236K 0.16% 207
2015
Q2
Sell
-800
Closed -$50K 658
2015
Q1
$50K Buy
+800
New +$50K 0.08% 284
2014
Q2
Sell
-7,500
Closed -$396K 592
2014
Q1
$396K Buy
+7,500
New +$396K 0.34% 102